Venture Planning Group: Market Research Reports

VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:

Biotechnology
Chemicals
Food processing
Electronics
Healthcare
Pharmaceuticals

Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:

Market segmentation
Competitive landscape
Regulatory policies
Latest technology trends
Acquisition evaluations
Vendors’ analysis, etc.

Publications found: 55,899

Sort by:

2017 Australia Infectious Disease Testing Market: Volume and Sales Forecasts for 100 Tests, Competitive Strategies, Innovative Technologies, Opportunities for Suppliers

US$ 4,050.00

... dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The infectious disease testing is one of the most rapidly ... technologies and their potential applications for infectious disease testing. Companies developing or marketing infectious disease diagnostic products by individual test. Opportunities and Strategic Recommendations Emerging opportunities ...

March 2017 950 pages

2017 Canada Infectious Disease Testing Market: Volume and Sales Forecasts for 100 Tests, Competitive Strategies, Innovative Technologies, Opportunities for Suppliers

US$ 4,050.00

March 2017 950 pages

2017 Armenia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

... over 40 blood typing, grouping and infectious disease screening tests, including NAT. Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious ... -MS, Mini-Sequencing Strategic Recommendations New product development opportunities for blood typing, grouping and infectious disease NAT assays and instrumentation with significant ...

March 2017 400 pages

2017 Australia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Austria Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Belgium Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Bulgaria Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Canada Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Croatia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Cyprus Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Czech Republic Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

... the next five years. Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd ... over 40 blood typing, grouping and infectious disease screening tests, including NAT. Current and Emerging Products Analysis of current and emerging blood typing, grouping ...

March 2017 400 pages

2017 Denmark Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Estonia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Finland Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Georgia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Greece Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Hungary Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Iceland Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Ireland Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Latvia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Luxembourg Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Malta Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Moldova Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Montenegro Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Netherlands Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Norway Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Poland Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Portugal Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Romania Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Serbia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Slovakia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Slovenia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Sweden Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Switzerland Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

US$ 3,105.00

March 2017 400 pages

2017 Australia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

March 2017 535 pages

2017 Austria Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

March 2017 535 pages

2017 Belgium Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

March 2017 535 pages

2017 Bulgaria Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

March 2017 535 pages

2017 Canada Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

March 2017 535 pages

2017 Cyprus Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

March 2017 535 pages

2017 Czech Republic Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests ...

March 2017 535 pages